Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

N Gianotti, L Galli, N Galizzi, M Ripa, A Andolina, S Nozza, V Spagnuolo, Andrea Poli, A Lazzarin, A Castagna

Research output: Contribution to journalArticle

Abstract

Purpose: To investigate if the regimen used when starting antiretroviral therapy (ART) affects the time spent with residual viraemia (RV) after achieving
Original languageEnglish
Pages (from-to)492-499
Number of pages8
JournalInternational Journal of Antimicrobial Agents
Volume52
Issue number4
DOIs
Publication statusPublished - 2018

Fingerprint

Viremia
HIV
RNA
Therapeutics

Cite this

Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen. / Gianotti, N; Galli, L; Galizzi, N; Ripa, M; Andolina, A; Nozza, S; Spagnuolo, V; Poli, Andrea; Lazzarin, A; Castagna, A.

In: International Journal of Antimicrobial Agents, Vol. 52, No. 4, 2018, p. 492-499.

Research output: Contribution to journalArticle

@article{39c43af8fc674e66a593754442636fa6,
title = "Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen",
abstract = "Purpose: To investigate if the regimen used when starting antiretroviral therapy (ART) affects the time spent with residual viraemia (RV) after achieving",
author = "N Gianotti and L Galli and N Galizzi and M Ripa and A Andolina and S Nozza and V Spagnuolo and Andrea Poli and A Lazzarin and A Castagna",
year = "2018",
doi = "10.1016/j.ijantimicag.2018.07.001",
language = "English",
volume = "52",
pages = "492--499",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

AU - Gianotti, N

AU - Galli, L

AU - Galizzi, N

AU - Ripa, M

AU - Andolina, A

AU - Nozza, S

AU - Spagnuolo, V

AU - Poli, Andrea

AU - Lazzarin, A

AU - Castagna, A

PY - 2018

Y1 - 2018

N2 - Purpose: To investigate if the regimen used when starting antiretroviral therapy (ART) affects the time spent with residual viraemia (RV) after achieving

AB - Purpose: To investigate if the regimen used when starting antiretroviral therapy (ART) affects the time spent with residual viraemia (RV) after achieving

U2 - 10.1016/j.ijantimicag.2018.07.001

DO - 10.1016/j.ijantimicag.2018.07.001

M3 - Article

VL - 52

SP - 492

EP - 499

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 4

ER -